Finance

Beta
Lists
TPST:NASDAQ
Tempest Therapeutics Inc
$1.27
0.00%
(0.00) 1D
Jun 8, 12:45:54 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TPST...
Open
$1.28
High
$1.31
Low
$1.26
Mkt. cap
18.80M
Avg. vol.
140.72K
Volume
46.32K
52-wk high
$12.22
52-wk low
$1.23
EPS
-$6.21
Beta
-1.85
Shares outstanding
14.81M
No. of employees
4
Open
$1.28
High
$1.31
Low
$1.26
Mkt. cap
18.80M
Avg. vol.
140.72K
Volume
46.32K
52-wk high
$12.22
52-wk low
$1.23
EPS
-$6.21
Beta
-1.85
Shares outstanding
14.81M
No. of employees
4
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to TPST in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for TPST in the last 3 months.
Highest
Current $1.27
$11.00 (+766.14%)
Average
$11.00 (+766.14%)
Lowest
$11.00 (+766.14%)
News stories
From sources across the web
About Tempest Therapeutics Inc
CEOStephen R. Brady
Employees4
Founded2011
HeadquartersBrisbane, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.87M
570.00K
539.00K
114.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.10M
3.03M
3.54M
5.42M
Operating expense
7.97M
3.60M
4.08M
5.54M
Total operating expenses
7.97M
3.60M
4.08M
5.54M
Operating income
-7.97M
-3.60M
-4.08M
-5.54M
Other non operating income
-
-
-
-
EBT including unusual items
-7.87M
-3.51M
-4.02M
-27.70M
EBT excluding unusual items
-7.87M
-3.51M
-4.02M
-5.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.87M
-3.51M
-4.02M
-27.70M
Net profit margin
-
-
-
-
Earnings per share
-2.07
-0.79
-0.62
-0.50
Interest and investment income
142.00K
86.00K
56.00K
23.00K
Interest expense
-46.00K
-
-
-
Net interest expenses
96.00K
86.00K
56.00K
23.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.90M
-3.53M
-4.01M
-5.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more